Author:
Sharma Tushar,Rastogi Anjay,Talwar Rishi,Goshtaseb Reza Khosravani,Kumar Rohit,Rashid Mohamad
Abstract
Although the etiology of hypertension is complicated and multifactorial, the role of sympathetic overactivity as part of the pathogenesis in essential hypertension has been well described in the literature. A promising new treatment modality of Renal Sympathetic Denervation has become prominent with very enthusiastic support. This paper suggests that while the support may be overhyped, this new treatment modality may, with further research, become a powerful tool for a specific patient population. The history, benefits, and limitations of the procedure are discussed including, but not limited to, proper screening methodology, technical aspects, and procedural complications.
Publisher
Bentham Science Publishers Ltd.